Profil
Jiri Adamec currently works at Novilytic LLC, as Director & Chief Scientific Officer.
Postes actifs de Jiri Adamec
Sociétés | Poste | Début |
---|---|---|
Novilytic LLC
Novilytic LLC Medical/Nursing ServicesHealth Services Novilytic LLC is a private company that focuses on the pharmaceutical bioreactor market. The company supply kits that enable molecular recognition and quantification, which were developed and validated in collaboration with pharmaceutical pilot partners and customers. The company is based in West Lafayette, IN. Novilytic has worked on a number of SBIR grants through the National Institute of Health and its associated institutes. The company is backed by more than 10 patents (and two pending), partnerships with multiple analytical instrument companies, 2 pharmaceutical consortiums, and analytical science universities. The company's technology helps ensure quality and consistency by recognizing molecular structure early and often, which saves time and reduces purification costs. The CEO of the company is Paul C. Dreier. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Novilytic LLC
Novilytic LLC Medical/Nursing ServicesHealth Services Novilytic LLC is a private company that focuses on the pharmaceutical bioreactor market. The company supply kits that enable molecular recognition and quantification, which were developed and validated in collaboration with pharmaceutical pilot partners and customers. The company is based in West Lafayette, IN. Novilytic has worked on a number of SBIR grants through the National Institute of Health and its associated institutes. The company is backed by more than 10 patents (and two pending), partnerships with multiple analytical instrument companies, 2 pharmaceutical consortiums, and analytical science universities. The company's technology helps ensure quality and consistency by recognizing molecular structure early and often, which saves time and reduces purification costs. The CEO of the company is Paul C. Dreier. | Health Services |